Allogeneic stem cell transplantation in patients with flt3-itd mutated aml: transplantation in cr1 is the decisive factor for good outcome
ConclusionsAlloSCT should be regarded as the urgency as soon as CR1 is achieved in this subset of AML patients.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants